Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Phase I, open study to assess the effect of ketoconazole, a marketed drug, on the way the
body handles the experimental drug cediranib, in patients with advanced cancer.